Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Lung Non-Small Cell Cancer AJCC v7”

341 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 341 results

Testing effectiveness (Phase 2)UnknownNCT03048500
What this trial is testing

Nivolumab and Metformin Hydrochloride in Treating Patients With Stage III-IV Non-small Cell Lung Cancer That Cannot Be Removed by Surgery

Who this might be right for
Recurrent Non-Small Cell Lung CarcinomaStage III Non-Small Cell Lung CancerStage IIIA Non-Small Cell Lung Cancer+2 more
Northwestern University 17
Large-scale testing (Phase 3)UnknownNCT03884192
What this trial is testing

Consolidation Sintilimab After Concurrent Chemoradiation in Patients With Unresectable Stage III NSCLC

Who this might be right for
Carcinoma, Non-Small Cell Lung
Shandong Cancer Hospital and Institute 162
Testing effectiveness (Phase 2)Looking for participantsNCT06563999
What this trial is testing

Neoadjuvant Umbrella Trial for Patients With Unresectable Stage III NSCLC Harboring Rare Mutations.

Who this might be right for
Lung Cancer Stage IIIMutation
Sun Yat-sen University 120
Testing effectiveness (Phase 2)Ended earlyNCT04765709
What this trial is testing

Durvalumab and Chemotherapy Induction Followed by Durvalumab and Radiotherapy in Large Volume Stage III NSCLC

Who this might be right for
Non-small Cell Lung Cancer Stage III
Mario Negri Institute for Pharmacological Research 10
Testing effectiveness (Phase 2)Study completedNCT00955175
What this trial is testing

Hypofractionated 3-Dimensional Radiation Therapy in Treating Patients With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer. ICORG 99-09

Who this might be right for
Lung Cancer
Cancer Trials Ireland 60
Large-scale testing (Phase 3)Study completedNCT00324805
What this trial is testing

Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage IIA Lung Non-Small Cell Carcinoma AJCC v7Stage IIB Lung Non-Small Cell Carcinoma AJCC v7+1 more
National Cancer Institute (NCI) 1,501
Testing effectiveness (Phase 2)Looking for participantsNCT06617936
What this trial is testing

Tislelizumab Combined With Recombinant Human Endostatin Combined With Chemotherapy for Unresectable Stage III Non-small Cell Lung Cancer.

Who this might be right for
Unresectable Non-small Cell Lung Cancer
Hua Zhang 36
Testing effectiveness (Phase 2)Study completedNCT00003072
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic Ovarian Cancer or Non-small Cell Lung Cancer

Who this might be right for
Lung CancerNeurotoxicityOvarian Cancer
University of California, San Francisco 80
Testing effectiveness (Phase 2)UnknownNCT01714908
What this trial is testing

Phase II Study of Erlotinib With Concurrent Radiotherapy in Unresectable NSCLC With Activating Mutation of EGFR in Exon 19 or 21

Who this might be right for
Non-small Cell Lung Cancer
Jinming Yu 100
Not applicableActive Not RecruitingNCT02194738
What this trial is testing

Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

Who this might be right for
Stage IB Lung Non-Small Cell Carcinoma AJCC v7Stage II Lung Non-Small Cell Cancer AJCC v7Stage IIA Lung Cancer AJCC v8+4 more
National Cancer Institute (NCI) 8,300
Large-scale testing (Phase 3)Study completedNCT00002911
What this trial is testing

Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
ILEX Oncology Services, Incorporated
Testing effectiveness (Phase 2)Study completedNCT01076231
What this trial is testing

Proton Beam Radiation Therapy and Chemotherapy in Treating Patients With Stage III Non-Small Cell Lung Cancer That Can Be Removed By Surgery

Who this might be right for
Stage IIIA Non-small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 34
Testing effectiveness (Phase 2)Study completedNCT00589056
What this trial is testing

Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Who this might be right for
Lung Cancer
Abramson Cancer Center at Penn Medicine 55
Early research (Phase 1)Study completedNCT01017133
What this trial is testing

Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Abramson Cancer Center at Penn Medicine 56
Testing effectiveness (Phase 2)WithdrawnNCT03370159
What this trial is testing

CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer

Who this might be right for
Stage IIIB Non-Small Cell Lung Cancer AJCC v7Stage IV Non-Small Cell Lung Cancer AJCC v7
Wake Forest University Health Sciences
Large-scale testing (Phase 3)Active Not RecruitingNCT02201992
What this trial is testing

Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Who this might be right for
ALK Gene RearrangementALK Gene TranslocationALK Positive+5 more
ECOG-ACRIN Cancer Research Group 166
Not applicableActive Not RecruitingNCT05049044
What this trial is testing

Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)

Who this might be right for
Non-Small Cell Lung Cancer
Groupe Francais De Pneumo-Cancerologie 413
Testing effectiveness (Phase 2)Active Not RecruitingNCT05740943
What this trial is testing

Induction Lorlatinib in Stage III Non-small Cell Lung Cancer

Who this might be right for
Stage III NSCLCSurgery
Guangdong Provincial People's Hospital 48
Testing effectiveness (Phase 2)Study completedNCT00463515
What this trial is testing

Evaluation of Carboplatin Plus Gemcitabine Followed by Concomitant Chemoradiation for Non-resectable Stage III NSCLC

Who this might be right for
Non-Small-Cell-Lung Cancer
University Hospital, Antwerp 77
Testing effectiveness (Phase 2)Study completedNCT00004160
What this trial is testing

Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Surgically Removed

Who this might be right for
Lung Cancer
University of Alabama at Birmingham 72
Load More Results